Clinical trials: PDAC
Pancreatic Ductal Adenocarcinoma
A Registry for BRCA Mutation Carriers With Pancreatic Ductal Adenocarcinoma
The purpose of this study is to better understand why pancreatic cancer develops in some people who are known carriers of the gene mutation (an abnormality) called BRCA, or its close relative PALB2.
- Trial name
- NCT01983410
- Testing
- The risk assessment questionnaire, Blood specimens, tumor tissue samples will be requested
- Where
- 13 sites in United States, Israel
- Volunteers
- 600 people, healthy volunteers welcome
- Sponsor
- Memorial Sloan Kettering Cancer Center